Loading...
Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
Androgen deprivation therapy (ADT) has been the standard of care for the last 75 years in metastatic hormone sensitive prostate cancer (PCa). However, this approach is rarely curative. Recent clinical trials have demonstrated that ADT combined with other agents, notably docetaxel and abiraterone, le...
Na minha lista:
| Udgivet i: | Asian J Urol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Second Military Medical University
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6363606/ https://ncbi.nlm.nih.gov/pubmed/30775249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2018.09.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|